U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI 
South Korea Inflation Hits Five-Month Low as CPI Reaches Central Bank Target 
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths 
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 
Tesla Launches New Model Y Variant in the US Starting at $41,990 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
JPMorgan Lifts Gold Price Forecast to $6,300 by End-2026 on Strong Central Bank and Investor Demand 
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates 
U.S. Stock Futures Slip as Markets Brace for Big Tech Earnings and Key Data 
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers 
Oil Prices Steady as Markets Weigh U.S.-Iran Talks, Dollar Strength Caps Gains 
India Budget 2025 Highlights Manufacturing Push but Falls Short of Market Expectations 
The International Agency for Research on Cancer (IARC), under the World Health Organization, is expected to classify aspartame, a widely-used artificial sweetener, as "possibly carcinogenic to humans" in July, reliable sources disclosed. Found in numerous food products, aspartame's classification aims to spur further investigation into its health effects.
Aspartame is found in numerous products, including Coca-Cola diet soda, Müller Light yogurts, Mars' Extra chewing gum, and more. While the IARC ruling, which was finalized earlier this month, aims to evaluate the potential hazards based on published evidence, it does not consider the safe consumption limits. Separate advice for individuals regarding the safe intake of aspartame is provided by the Joint WHO and Food and Agriculture Organization's Expert Committee on Food Additives (JECFA), as well as determinations from national regulators.
On the 14th of July, both the IARC and JECFA are expected to announce their findings. JECFA has historically declared aspartame safe for consumption within accepted daily limits since 1981. To pose a risk, an adult weighing 60 kg (132 pounds) would need to consume an excessive daily amount of 12 to 36 cans of diet soda, depending on the aspartame content in each beverage.
Although the IARC and JECFA findings remain confidential until July, an IARC spokesperson disclosed that these results are complementary and represent important steps in understanding the possible carcinogenicity of aspartame. However, it is crucial to note that the IARC is not a food safety authority. The WHO's JECFA is currently conducting a comprehensive food safety review of aspartame, and any conclusions should be drawn only after both reports are published.
Despite the ongoing debate, it is worth mentioning that aspartame has undergone extensive research, endorsed as safe by over 90 food safety agencies worldwide. The European Food Safety Authority conducted the most comprehensive safety evaluation of aspartame to date.
It is worth noting that a recent observational study conducted in France among 100,000 adults showed a potential association between artificial sweeteners, particularly aspartame and acesulfame-K, and increased cancer risk.
Together, these developments shed light on the upcoming assessment of aspartame's potential risks and its impact on consumer safety.
According to the sources closely associated with the International Agency for Research on Cancer (IARC), the inclusion of aspartame as a potential carcinogen is aimed at stimulating further investigation. This revelation comes just a month after the World Health Organization (WHO) released guidelines cautioning individuals against using non-sugar sweeteners for weight management.
Photo: Brett Jordan/Unsplash
